SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: BigKNY3 who wrote (19273)3/7/1999 4:39:00 PM
From: DaiS  Read Replies (3) of 23519
 
BigKNY3 = ViagraUser65

Sorry BigK only joking!

You used the term "national formulary" with reference to UK in your message to Vlad, and VU65 on yahoo used the same term today also.

I come from the UK and I never heard this term before, it is not in common parlance, so I guess is technical term used in drug/pharmacy industry.

VU65 gets a lot of stuff from here so that is my preferred hypothesis <g>.

BigK, the Astra muse revenues,

Q3 revenue = $3.911 M
Q4 revenue = $3.154 M

Decline in specification Q3 to Q4 = 19.4%. You just gotta admit that the decline could have been much worse based on the US experience of viagra effect and augurs well for muse sales outside US. And I understand that the absolute amounts reflect only sales through specialists in the UK.

DaiS

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext